SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-18-055613
Filing Date
2018-10-29
Accepted
2018-10-26 17:54:21
Documents
5
Period of Report
2018-10-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tv505494_8-ka.htm 8-K/A 21007
2 EXHIBIT 23.1 tv505494_ex23-1.htm EX-23.1 2592
3 EXHIBIT 99.1 tv505494_ex99-1.htm EX-99.1 114176
4 EXHIBIT 99.2 tv505494_ex99-2.htm EX-99.2 83935
5 EXHIBIT 99.3 tv505494_ex99-3.htm EX-99.3 183687
  Complete submission text file 0001144204-18-055613.txt   406757
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37939 | Film No.: 181142471
SIC: 2834 Pharmaceutical Preparations